Vasopressin - Not only good news!

Critical Care Medicine

Volumn 30, Issue 11, 2002, Pages 2604-2605

  Bone, Hans G ^a   Westphal, Martin ^a   Van Aken, Hugo C ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Arginine vasopressin; Pulmonary hypertension; Right ventricular function

Indexed keywords

ARGIPRESSIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EPHEDRINE; TERLIPRESSIN; THROMBOXANE DERIVATIVE; VASOPRESSIN;

DRUG EFFICACY; DRUG SAFETY; EDITORIAL; HEART MUSCLE ISCHEMIA; HEART VENTRICLE FIBRILLATION; HEMODYNAMICS; HUMAN; HYPOTENSION; INOTROPISM; PRIORITY JOURNAL; SEPTIC SHOCK;

EID: 0036851128     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200211000-00040     Document Type: Editorial

References (14)

1. Lindner KH, Dirks B, Strohmenger HU, et al: Randomised comparison of epinephrine and vasopressin in patients with out-of-hospital ventricular fibrillation. Lancet 1997; 349:535-537
2. Guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. International consensus on science. Circulation 2000; 102(Suppl): I-1-384
3. Tsuneyoshi I, Yamada H, Kakihana Y, et al: Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock. Crit Care Med 2001; 29:487-493
4. Landry DW, Levin HR, Gallant EM, et al: Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 1997; 95:1122-1125
5. O'Brien A, Clapp L, Singer M: Terlipressin for norepinephrine-resistant septic shock. Lancet 2002; 359:1209-1210
6. Morales DL, Gregg D, Helman DN, et al: Arginine vasopressin in the treatment of 50 patients with postcardiotomy vasodilatory shock. Ann Thorac Surg 2000; 69:102-106
7. Argenziano M, Choudhri AF, Oz MC, et al: A prospective randomized trial of arginine vasopressin in the treatment of vasodilatory shock after left ventricular assist device placement. Circulation 1997; 96:II-286-290
8. Eyraud D, Brabant S, Nathalie D, et al: Treatment of intraoperative refractory hypotension with terlipressin in patients chronically treated with an antagonist of the reninangiotensin system. Anesth Analg 1999; 88:980-984
9. Meersschaert K, Brun L, Gourdin M, et al: Terlipressin-ephedrine versus ephedrine to treat hypotension at the induction of anesthesia in patients chronically treated with angiotensin converting-enzyme inhibitors: A prospective, randomized, double-blinded, crossover study. Anesth Analg 2002; 94:835-840
10. Leather HA, Segers P, Berends N, et al: Effects of vasopressin on right ventricular function in an experimental model of acute pulmonary hypertension. Crit Care Med 2002; 30:2548-2552
11. Scharte M, Meyer J, Van Aken H, et al: Hemodynamic effects of terlipressin (a synthetic analog of vasopressin) in healthy and endotoxemic sheep. Crit Care Med 2001; 29:1756-1760
12. Westphal M, Freise H, Eicker K, et al: Arginine vasopressin compromises gut mucosal microcirculation in septic rats. Crit Care Med 2002; 30(Suppl):S62
13. Medel J, Boccara G, Van de Steen E, et al: Terlipressin for treating intraoperative hypotension: Can it unmask myocardial ischemia? Anesth Analg 2001; 93:53-55
14. Holmes CL, Patel BM, Russell JA, et al: Physiology of vasopressin relevant to management of septic shock. Chest 2001; 120:989-1002